The bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein

Anti-Cancer Drugs

Volumn 9, Issue 3, 1998, Pages 255-261

  Choi, Sang Un ^a   Park, Sung Hee ^a   Kim, Kwang Hee ^a   Choi, Eun Jung ^a   Kim, Shin ^a   Park, Woo Kyu ^a   Zhang, Yong He ^b   Kim, Hack Seang ^b   Jung, Noh Pal ^c   Lee, Chong Ock ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Chungbuk National University   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Fangchinoline; MDR reversal; Multidrug resistance; P glycoprotein; Tetrandrine

Indexed keywords

ANTINEOPLASTIC ALKALOID; BENZYLISOQUINOLINE DERIVATIVE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DACTINOMYCIN; FANGQUINOLINE; GLYCOPROTEIN P; RHODAMINE 123; TETRANDRINE; VERAPAMIL;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL GROWTH; CONTROLLED STUDY; DRUG CYTOTOXICITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 7144259744     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199803000-00008     Document Type: Article

References (20)

1. Lum BL, Gosland MP, Kaubisch S, Sikic BI. Molecular targets in oncology: implications of the multidrug resistance gene. Pharmacotherapy 1993; 13: 88-109.
2. Endicott JA, Ling V. The biochemistry of P-glycoprotein mediated multidrug resistance. Anna Rev Biochem 1989; 58: 137-71.
3. Ueda K, Cardarelli G, Gottesman MM, Pastan I. Expression of a full length cDNA for the human MDR-1 gene confers resistance to colchicine, doxorubicin, and vinblastin. Proc Natl Acad Sci USA 1987; 84: 3004-8.
4. Choi SU, Kim NY, Choi EJ, Kim KH, Lee CO. Establishment of doxorubicin-resistant subline derived from HCT15 human colorectal cancer cells. Arch Pharm Res 1996; 19: 342-7.
5. Sutter MC, Wang YX. Recent cardiovascular drugs from Chinese medical plants. Cardiovasc Res 1993; 27: 1891-901.
6. Xing SG, Shi XC, Wu ZL, Whong WZ, Ong T. Effect of tetrandine on micronucleus formation and sister-chromatid exchange in both in vitro and in vivo assays. Mutat Res 1989; 224: 5-10.
7. 2+-channel blocker. Proc Natl Acad Sci USA 1993; 90: 9523-7.
8. Liu QY, Karpinski E, Pang PK. Tetrandrine inhibits both T and L calcium channel currents in ventricular cell. J Cardiovasc Pharmacol 1992; 20: 513-9.
9. Leung YM, Kwan CY, Loh TT. Dual effects of tetrandrine on cytosolic calcium in human leukemic HL-60 cells; intracellular calcium release and calcium entry blocker. Br J Pharmacol 1994; 113: 767-74.
10. Takemura H, Kwan CY, Ohshika H. Calcium antagonistic actions of tetrandrine depend on cell types. Res Commun Mol Pathol Pharmacol 1995; 90: 59-68.
11. Ozols RF, Cunnion RE, Klecker RW, et al. Verapamil and doxorubicin in the treatment of drug-resistant ovarian cancer patients. J Clin Oncol 1987; 5: 641-7.
12. Yamaguchi K. Spectral data of natural products. Amsterdam: Elsevier 1970; 1: 559.
13. Lee J, Paull K, Alvarez M, et al. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol Pharmacol 1994; 46: 627-38.
14. Speicher LA, Barone LR, Chapman AE, et al. P-glycoprotein binding and modulation of the multidrug resistant phenotype by estramustine. J Natl Cancer Inst 1994; 86: 688-94.
15. Skehan P, Sterng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107-12.
16. Choi SU, Lee BH, Kim KH, et al. Novel multidrugresistance modulators, KR-30026 and KR-30031, in cancer cells. Anticancer Res 1997; in press.
17. Perez RP, Hamilton TC, Ozoles RF, Young RC. Mechanisms and modulation of resistance to chemotherapy in ovarian cancer. Cancer 1993; 71: 1571-80.
18. Iwahashi T, Okochi E, Ono K, Sugawara I, Tsuruo T, Mori S. Establishment of multidrug resistant human colorectal carcinoma HCT15 cell lines and their properties. Anticancer Res 1991; 11: 1309-12.
19. Hotta T, Tanimura H, Yamaue H, et al. Modulation of multidrug resistance by cepharanthine in fresh human gastrointestinal tumor cells. Oncology 1997; 54: 153-7.
20. Gottesman MM. How cancer cells evade chemotherapy. Cancer Res 1993; 53: 747-54.